Wen Xia
Rutgers, The State University of New Jersey(US)Anhui Medical University(CN)Harbin Institute of Technology(CN)Ningxia Medical University(CN)Zhejiang Provincial People's Hospital(CN)First Affiliated Hospital of Anhui Medical University(CN)The Fourth People's Hospital of Ningxia Hui Autonomous Region(CN)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Drug Transport and Resistance Mechanisms, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies
Most-Cited Works
- → Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment(2020)218 cited
- → Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway(2015)83 cited
- → Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Breast Cancer: A Propensity Score-Matching Study(2020)74 cited
- → Transgenic Expression of the Human MRP2 Transporter Reduces Cisplatin Accumulation and Nephrotoxicity in Mrp2-Null Mice(2014)60 cited
- → Profiling of Kidney Injury Biomarkers in Patients Receiving Cisplatin: Time‐dependent Changes in the Absence of Clinical Nephrotoxicity(2016)49 cited
- → Preventing BRCA1/ZBRK1 repressor complex binding to the GOT2 promoter results in accelerated aspartate biosynthesis and promotion of cell proliferation